PAVM PAVmed Inc. - Common Stock
NASDAQ · Health Care · 在 SEC EDGAR 上查看 ↗ 收盘 十月 2, 2026 10-K/10-Q 八月 13, 2026
$2.87
· % 处于52周区间
· 高于低点
· 至高点
$2.6152周低点
$28.4452周高点
市值 (MRQ)
$18M
P/E (TTM)
-0.3
EPS (TTM)
$-10.52
收入 (TTM)
$112.0K
PAVM 股票快照 价格、市值、P/E、EPS、ROE、负债/权益、52周范围
价格
$2.87
市值 (MRQ)
$18M
P/E (TTM)
-0.3
EPS (TTM)
$-10.52
收入 (TTM)
$112.0K
ROE (TTM)
-33.3%
52周区间
$3–$28
PAVM 股价图表 包含技术指标的日 OHLCV — 平移、缩放和自定义您的视图
区间
条形图
柱状图粒度会根据所选周期进行调整 — 将鼠标悬停在图表上可查看柱状图的开盘价/最高价/最低价/收盘价。
股票拆分
| 除息日 | 拆股 | 类型 |
|---|---|---|
| 2026年1月2日 | 1-for-30 | 反向 |
| 2023年12月7日 | 1-for-15 | 反向 |
10年表现 收入、净利润、利润率和每股收益趋势
收入$71.0K2021-12-31 → 2025-12-31
EPS$-5.632022-12-31 → 2025-12-31
自由现金流$-5M2020-12-31 → 2025-12-31
净利率-10794.6%2021-12-31 → 2025-12-31
估值与比率
估值 P/E、P/S、P/B、EV/EBITDA 比率 — 该股票是昂贵还是便宜？
| 指标 | 5年趋势 | PAVM | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| P/E (TTM) | -0.35年均值 ≈-0.5 | ≈-0.5 | · | · | |
| P/S (TTM) | 160.75年均值 ≈1656.4 | ≈1656.4 | 2.1 | 估值过高 | |
| 市净率 (MRQ) | 0.55年均值 ≈-4.4 | ≈-4.4 | 3.5 | 低估 | |
| 股价/自由现金流 (TTM) | -2.35年均值 ≈-17.4 | ≈-17.4 | · | · | |
| 市现率 (TTM) | -2.35年均值 ≈-18.0 | ≈-18.0 | · | · | |
| Price / Tangible Book (市净率（有形资产）) | 0.1 | · | · | · |
同行中位数按每项指标的标准化基础计算，可能与本股票显示的TTM/MRQ基础不完全匹配。
盈利能力 毛利率、营业利润率和净利率；股本回报率 (ROE)、资产回报率 (ROA)、投入资本回报率 (ROIC)
| 指标 | 5年趋势 | PAVM | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| 营业利润率 (TTM) | -23841.1%5年均值 ≈-13988.9% | ≈-13988.9% | -6.6% | 弱 | |
| 息税折旧摊销前利润率 (TTM) | -23770.5%5年均值 ≈-13797.5% | ≈-13797.5% | -4.6% | 弱 | |
| 税前利润率 (TTM) | -14669.6%5年均值 ≈-8861.9% | ≈-8861.9% | -11.8% | 弱 | |
| 净利润率 (TTM) | -10794.6%5年均值 ≈-6869.6% | ≈-6869.6% | -12.2% | 弱 | |
| ROA (TTM) | -28.7%5年均值 ≈-48.4% | ≈-48.4% | 1.1% | 持平 | |
| ROE (TTM) | -33.3%5年均值 ≈-87.6% | ≈-87.6% | -103.4% | 顶尖 | |
| ROIC | -64.2% | · | -14.5% | 弱 |
财务健康 债务、流动性、偿付能力 — 资产负债表强度
| 指标 | 5年趋势 | PAVM | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| 流动比率 (MRQ) | 1.25年均值 ≈0.4 | ≈0.4 | 1.4 | 低流动性 | |
| Quick Ratio (速动比率) | 0.15年均值 ≈0.4 | ≈0.4 | 0.8 | 流动性强 |
成长 营收、每股收益 (EPS) 和净利润增长：同比、3年复合年增长率 (CAGR)、5年复合年增长率 (CAGR)
| 指标 | 5年趋势 | PAVM | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| Revenue YoY (营收同比增长) | -97.6%5年均值 ≈115.2% | ≈115.2% | · | · | |
| Revenue CAGR 3Y (营收3年复合年增长率) | -42.7% | · | · | · | |
| Net Income YoY (净利润同比增长) | -99.0% | · | · | · |
资本效率 资产周转率、库存周转率、应收账款周转率
| 指标 | 5年趋势 | PAVM | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| Asset Turnover (资产周转率) | 0.05年均值 ≈0.0 | ≈0.0 | 0.9 | 弱 | |
| Receivables Turnover (应收账款周转率) | 4.35年均值 ≈30.6 | ≈30.6 | 6.0 | 弱 | |
| Revenue / Employee (年营业收入 ÷ 员工人数（报告的 headcount，yfinance）。衍生数据 — 非存储的 SEC-XBRL 概念。) | ≈$1.7K | · | · | · |
价值 · ≈ 5年均值 · 行业中值 · 相对于中值的评判
收益历史 每股收益实际值 vs 预估值，惊喜%，达标率，下次财报日期
平均惊喜
-88.5%
下次报告
十一月 10, 2026
| 期间 | 报告 | EPS Actual | EPS 预期 | 惊喜 |
|---|---|---|---|---|
| 2026年6月30日 | 八月 11, 2026 | $-0.87 | $-0.48 | -81.5% |
| 2026年3月31日 | 五月 14, 2026 | $-4.42 | $-0.71 | -519.0% |
| 2025年12月31日 | $-5.52 | $-5.51 | -0.22% | |
| 2025年9月30日 | $-8.70 | $-5.20 | -67.2% | |
| 2025年6月30日 | $-22.20 | $-3.98 | -458.1% | |
| 2025年3月31日 | $10.20 | $-3.98 | 356.4% | |
| 2024年12月31日 | $8.70 | $-17.44 | 149.9% |
完整基本面 所有年度指标 — 损益表、资产负债表、现金流量表
损益表
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Revenue | $71.0K | $3M | $2M | $377.0K | $500.0K | |
| Cost of Revenue | $218.0K | $5M | $6M | $4M | $585.0K | |
| Gross Profit | · | · | · | · | $-85.0K | |
| R&D Expense | $4M | $6M | $14M | $25M | $20M | |
| SG&A Expense | $16M | $25M | $31M | $41M | $25M | |
| Operating Expenses | $22M | $47M | $71M | $91M | $55M | |
| Operating Income | $-22M | $-44M | $-69M | $-91M | $-54M | |
| Interest Income | $29.0K | $254.0K | $505.0K | $169.0K | · | |
| Other Non-op | $19M | $73M | $-10M | $-12M | $-2M | |
| Pretax Income | $-2M | $28M | $-79M | $-103M | $-56M | |
| Income Tax | $0 | $0 | · | · | · | |
| Net Income | $401.0K | $40M | $-64M | $-89M | $-50M | |
| EPS (Basic) | $-5.63 | $99.15 | $-9.16 | $-15.03 | $-0.65 | |
| EPS (Diluted) | $-5.63 | $14.90 | $-9.16 | $-15.03 | · | |
| Shares (Basic) | 670,466 | 322,407 | 7,231,546 | 5,938,406 | 77,515,767 | |
| Shares (Diluted) | 670,466 | 2,173,398 | 7,231,546 | 5,938,406 | · | |
| EBITDA | $-22M | $-43M | $-66M | $-88M | $-54M |
资产负债表
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $2M | $1M | $20M | $40M | $77M | |
| Receivables | $15.0K | $18.0K | $61.0K | $17.0K | $200.0K | |
| Inventory | · | · | $278.0K | $111.0K | · | |
| Prepaid Expense | $1M | $961.0K | $5M | $4M | $5M | |
| Current Assets | $3M | $2M | $24M | $44M | $83M | |
| PP&E (Net) | $77.0K | $151.0K | $2M | $2M | $2M | |
| PP&E (Gross) | $1M | $1M | $4M | $3M | $2M | |
| Accum. Depreciation | $1M | $1M | $2M | $808.0K | $138.0K | |
| Intangibles | · | · | $1M | $3M | $2M | |
| Other Non-current Assets | $56.0K | $208.0K | $1M | $1M | $725.0K | |
| Total Assets | $39M | $31M | $33M | $54M | $87M | |
| Accounts Payable | $678.0K | $657.0K | $2M | $3M | $3M | |
| Accrued Liabilities | $2M | $5M | $7M | $4M | $4M | |
| Current Liabilities | $15M | $35M | $54M | $41M | $8M | |
| Capital Leases | $2M | $2M | $3M | $2M | · | |
| Total Liabilities | $17M | $38M | $57M | $43M | $8M | |
| Common Stock | $1.0K | $1.0K | $9.0K | $6.0K | $86.0K | |
| Paid-in Capital | $268M | $249M | $238M | $216M | $198M | |
| Retained Earnings | $-259M | $-255M | $-294M | $-228M | $-139M | |
| Treasury Stock | · | · | · | $408.0K | · | |
| Stockholders' Equity | $34M | $-2M | $-54M | $-10M | $62M | |
| Liabilities + Equity | $39M | $31M | $33M | $54M | $87M | |
| Shares Outstanding | 927,934 | 373,300 | 8,578,505 | 6,300,703 | 86,367,845 |
现金流
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| D&A | $105.0K | $1M | $3M | $2M | $226.0K | |
| Stock-based Comp | $2M | $6M | $11M | $20M | $15M | |
| Amort. of Intangibles | $0 | $559.0K | $2M | $2M | $146.0K | |
| Other Non-cash | $-7M | $-81M | $-2M | $-4M | · | |
| Operating Cash Flow | $-5M | $-34M | $-52M | $-71M | $-41M | |
| CapEx | $31.0K | $55.0K | $242.0K | $2M | $1M | |
| Investing Cash Flow | $-31.0K | $-16M | $758.0K | $-5M | $-4M | |
| Stock Issued | · | $2M | $2M | $79.0K | $55M | |
| Net Stock Activity | · | $2M | $2M | · | $55M | |
| Financing Cash Flow | $6M | $31M | $31M | $38M | $104M | |
| Net Change in Cash | $353.0K | $-18M | $-20M | $-38M | $60M | |
| Taxes Paid | $0 | · | · | · | · | |
| Free Cash Flow | $-5M | $-34M | $-52M | $-73M | $-42M |
盈利能力
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Gross Margin | · | · | · | · | -17.0% | |
| Operating Margin | -30712.7% | -1482.9% | -2751.8% | -24118.6% | -10878.6% | |
| Net Margin | 564.8% | 1326.4% | -2567.0% | -23602.9% | -10069.4% | |
| Pretax Margin | -3477.5% | 947.6% | -3170.5% | -27384.1% | -11225.2% | |
| EBITDA Margin | -30564.8% | -1443.0% | -2634.5% | -23466.8% | -10878.6% | |
| ROA | 1.1% | 124.8% | -147.4% | -126.3% | -94.3% | |
| ROE | 2.2% | -141.3% | 202.1% | -342.3% | -158.4% | |
| ROIC | -64.2% | · | · | · | · |
流动性与偿付能力
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Current Ratio | 0.2 | 0.1 | 0.5 | 1.1 | · | |
| Quick Ratio | 0.1 | 0.0 | 0.4 | 1.0 | · |
效率
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.1 | 0.1 | 0.0 | 0.0 | |
| Inventory Turnover | · | · | 33.0 | · | · | |
| Receivables Turnover | 4.3 | 75.9 | 64.1 | 3.5 | 5.0 |
每股
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Book Value / Share | $36.60 | $-0.22 | $-6.28 | $-0.10 | $0.71 | |
| Revenue / Share | $0.11 | $0.05 | $0.35 | · | · | |
| Cash Flow / Share | $-7.76 | $-0.51 | $-7.20 | · | · | |
| Cash / Share | $1.66 | $0.11 | $2.29 | $0.42 | $0.89 | |
| EPS (TTM) | $-5.63 | $14.90 | $-9.16 | $-15.03 | · |
增长率
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Revenue YoY | -97.6% | 19.8% | 563.1% | -24.6% | · | |
| Revenue CAGR 3Y | -42.7% | 81.6% | · | · | · | |
| Net Income YoY | -99.0% | · | · | · | · |
估值 (TTM)
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Revenue TTM | $71.0K | $3M | $2M | $377.0K | $500.0K | |
| Net Income TTM | $401.0K | $40M | $-64M | $-89M | $-50M | |
| Market Cap | $6M | $7M | $35M | $680M | $3.19B | |
| P/E | -1.2 | 0.0 | -0.4 | -0.5 | · | |
| P/S | 86.7 | 2.3 | 14.1 | 1805.0 | 6373.9 | |
| P/B | 0.2 | -2.8 | -0.7 | -70.3 | 51.7 | |
| P / Tangible Book | 0.2 | · | · | · | 53.4 | |
| P / Cash Flow | -1.2 | -0.2 | -0.7 | -9.6 | -78.5 | |
| P / FCF | -1.2 | -0.2 | -0.7 | -9.4 | -75.8 | |
| Earnings Yield | -84.9% | 2372.6% | -222.3% | -208.8% | · |
损益表
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $33.0K | $22.0K | $52.0K | $5.0K | $6.0K | $8.0K | $10.0K | $996.0K | $979.0K | $1M | · | $791.0K | $166.0K | $446.0K | · | $76.0K | |
| Cost of Revenue | $122.0K | $97.0K | $86.0K | $55.0K | $41.0K | $36.0K | $49.0K | $1M | $2M | $2M | $2M | $2M | $2M | $1M | $2M | $2M | |
| R&D Expense | $2M | $1M | $2M | $1M | $790.0K | $787.0K | $808.0K | $2M | $2M | $2M | $4M | $3M | $3M | $4M | $6M | $6M | |
| SG&A Expense | $5M | $6M | $5M | $4M | $4M | $4M | $4M | $7M | $7M | $7M | $7M | $7M | $7M | $10M | $10M | $10M | |
| Operating Expenses | $7M | $8M | $7M | $5M | $5M | $5M | $5M | $13M | $15M | $15M | $17M | $16M | $17M | $21M | $25M | $23M | |
| Operating Income | $-7M | $-8M | $-7M | $-5M | $-5M | $-5M | $-5M | $-12M | $-14M | $-14M | $-16M | $-16M | $-16M | $-20M | $-25M | $-23M | |
| Interest Expense | · | · | · | · | $26.0K | $26.0K | · | · | · | · | · | · | · | · | · | · | |
| Interest Income | $10.0K | $19.0K | $3.0K | $10.0K | $8.0K | $8.0K | $2.0K | $70.0K | $110.0K | $72.0K | $97.0K | $124.0K | $163.0K | $121.0K | $106.0K | $54.0K | |
| Other Non-op | $0 | $-40.0K | $4M | $-1M | $0 | $0 | $6M | $72M | $-1M | $-4M | $-1M | $-6M | $-1M | $-2M | $29.0K | $-7M | |
| Pretax Income | $-7M | $-1M | $-3M | $-6M | $-12M | $19M | $1M | $61M | $-15M | $-19M | $-17M | $-22M | $-18M | $-22M | $-25M | $-30M | |
| Income Tax | $0 | $0 | · | · | $0 | $0 | · | · | · | · | · | · | · | · | · | · | |
| Net Income | $-5M | $-60.0K | $-1M | $-5M | $-12M | $19M | $1M | $64M | $-11M | $-15M | $-14M | $-18M | $-15M | $-18M | $-20M | $-26M | |
| EPS (Basic) | $-0.87 | $-4.42 | $-5.88 | $-0.29 | $-22.08 | $38.26 | $96.53 | $6.43 | $-1.19 | $-2.62 | $-1.90 | $-2.38 | $-2.10 | $-2.78 | $-14.25 | $-0.29 | |
| EPS (Diluted) | $-0.87 | $-4.42 | $-4.94 | $-0.29 | $-22.08 | $10.10 | $17.27 | $1.44 | $-1.19 | $-2.62 | $-1.90 | $-2.38 | $-2.10 | $-2.78 | $-14.25 | $-0.29 | |
| Shares (Basic) | 6,269,384 | 1,580,788 | · | 21,554,546 | 602,822 | 462,539 | · | 10,005,379 | 9,152,819 | 8,694,904 | · | 7,462,751 | 6,956,655 | 6,473,010 | · | 89,758,927 | |
| Shares (Diluted) | 6,269,384 | 1,580,788 | · | 21,554,546 | 602,822 | 1,746,739 | · | 44,475,638 | 9,152,819 | 8,694,904 | · | 7,462,751 | 6,956,655 | 6,473,010 | · | 89,758,927 | |
| EBITDA | $-7M | $-8M | · | $-5M | $-5M | $-5M | · | $-12M | $-14M | $-13M | · | $-16M | $-16M | $-20M | · | $-23M |
资产负债表
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $4M | $6M | $2M | $3M | $4M | $3M | $1M | $765.0K | $25M | $26M | $20M | $26M | $37M | $49M | $40M | $57M | |
| Receivables | $16.0K | $21.0K | $15.0K | $3.0K | $3.0K | $9.0K | $18.0K | $16.0K | $219.0K | $67.0K | $61.0K | $36.0K | $41.0K | $27.0K | $17.0K | $31.0K | |
| Inventory | · | · | · | · | · | · | · | $6.0K | $687.0K | $410.0K | $278.0K | · | · | · | $111.0K | · | |
| Prepaid Expense | $1M | $933.0K | $1M | $1M | $1M | $929.0K | $961.0K | $1M | $4M | $4M | $5M | $6M | $6M | $5M | $4M | $5M | |
| Current Assets | $5M | $7M | $3M | $4M | $5M | $4M | $2M | $2M | $30M | $30M | $24M | $32M | $43M | $54M | $44M | $62M | |
| PP&E (Net) | $73.0K | $79.0K | $77.0K | $81.0K | $100.0K | $114.0K | $151.0K | $216.0K | $1M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | |
| PP&E (Gross) | · | · | $1M | · | · | · | $1M | · | · | · | $4M | · | · | · | $3M | · | |
| Accum. Depreciation | · | · | $1M | · | · | · | $1M | · | · | · | $2M | · | · | · | $808.0K | · | |
| Intangibles | · | · | · | · | · | · | · | · | $947.0K | $1M | $1M | $2M | $2M | $3M | $3M | $4M | |
| Other Non-current Assets | $51.0K | $56.0K | $56.0K | $51.0K | $51.0K | $51.0K | $208.0K | $75.0K | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | |
| Total Assets | $40M | $45M | $39M | $38M | $44M | $53M | $31M | $31M | $39M | $37M | $33M | $42M | $54M | $65M | $54M | $72M | |
| Accounts Payable | $1M | $983.0K | $678.0K | $342.0K | $387.0K | $369.0K | $657.0K | $465.0K | $1M | $1M | $2M | $2M | $1M | $1M | $3M | $2M | |
| Accrued Liabilities | $2M | $2M | $2M | $3M | $3M | $2M | $5M | $5M | $7M | $7M | $7M | $5M | $5M | $4M | $4M | $3M | |
| Current Liabilities | $4M | $4M | $15M | $10M | $11M | $10M | $35M | $38M | $53M | $55M | $54M | $55M | $51M | $51M | $41M | $42M | |
| Capital Leases | $1M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $5M | $3M | $3M | $3M | $4M | $4M | $2M | $2M | |
| Total Liabilities | $21M | $20M | $17M | $12M | $12M | $12M | $38M | $40M | $58M | $58M | $57M | $58M | $55M | $54M | $43M | $44M | |
| Common Stock | $6.0K | $6.0K | $1.0K | $23.0K | $20.0K | $17.0K | $1.0K | $11.0K | $10.0K | $9.0K | $9.0K | $120.0K | $109.0K | $101.0K | $6.0K | $92.0K | |
| Paid-in Capital | $296M | $295M | $268M | $265M | $264M | $256M | $249M | $248M | $244M | $238M | $238M | $232M | $226M | $221M | $216M | $214M | |
| Retained Earnings | $-265M | $-259M | $-259M | $-257M | $-251M | $-237M | $-255M | $-256M | $-321M | $-310M | $-294M | $-279M | $-261M | $-246M | $-228M | $-208M | |
| Treasury Stock | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $408.0K | $408.0K | |
| Stockholders' Equity | $35M | $40M | $34M | $33M | $38M | $45M | $-2M | $-5M | $-74M | $-69M | $-54M | $-43M | $-32M | $-22M | $-10M | $9M | |
| Liabilities + Equity | $40M | $45M | $39M | $38M | $44M | $53M | $31M | $31M | $39M | $37M | $33M | $42M | $54M | $65M | $54M | $72M | |
| Shares Outstanding | 6,269,418 | 6,269,384 | 927,934 | 23,053,498 | 20,142,463 | 16,769,619 | 373,300 | 10,660,394 | 9,554,381 | 8,858,597 | 8,578,505 | 119,701,959 | 108,537,994 | 100,596,406 | 6,300,703 | 92,228,862 |
现金流
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $19.0K | $20.0K | $18.0K | $22.0K | $22.0K | $43.0K | $69.0K | $238.0K | $305.0K | $586.0K | $725.0K | $733.0K | $747.0K | $727.0K | $726.0K | $700.0K | |
| Stock-based Comp | $917.0K | $182.0K | $232.0K | $383.0K | $162.0K | $930.0K | $732.0K | $2M | $2M | $2M | $2M | $2M | $3M | $4M | $5M | $5M | |
| Amort. of Intangibles | · | · | · | · | · | · | $0 | $82.0K | $105.0K | $372.0K | $506.0K | $505.0K | $505.0K | $505.0K | $506.0K | $505.0K | |
| Other Non-cash | · | $-3M | · | · | · | $-22M | · | · | · | $-365.0K | · | · | · | $-4M | · | · | |
| Operating Cash Flow | $-3M | $-3M | $-2M | $-896.0K | $-1M | $-2M | $94.0K | $-9M | $-12M | $-13M | $-12M | $-11M | $-13M | $-16M | $-17M | $-19M | |
| CapEx | $13.0K | $22.0K | $14.0K | $3.0K | $8.0K | $6.0K | $4.0K | $6.0K | $3.0K | $42.0K | $183.0K | $18.0K | $15.0K | $26.0K | $298.0K | $316.0K | |
| Investing Cash Flow | $-13.0K | $-22.0K | $-14.0K | $-3.0K | $-8.0K | $-6.0K | $-4.0K | $-16M | $-3.0K | $-42.0K | $-183.0K | $-18.0K | $-15.0K | $974.0K | $-298.0K | $-1M | |
| Stock Issued | · | · | · | $0 | $0 | $841.0K | · | $284.0K | $198.0K | $786.0K | $367.0K | $0 | $609.0K | $557.0K | · | · | |
| Net Stock Activity | · | · | · | · | · | $841.0K | · | · | · | $786.0K | · | · | · | · | · | · | |
| Financing Cash Flow | $0 | $8M | $0 | $-2.0K | $2M | $3M | $330.0K | $284.0K | $12M | $19M | $5M | $352.0K | $684.0K | $25M | $80.0K | $12M | |
| Net Change in Cash | $-3M | $5M | $-2M | $-901.0K | $1M | $2M | $420.0K | $-25M | $-37.0K | $6M | $-7M | $-11M | $-12M | $10M | $-17M | $-8M | |
| Free Cash Flow | · | $-3M | · | · | · | $-2M | · | · | · | $-13M | · | · | · | $-16M | · | · |
盈利能力
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -21278.8% | -36522.7% | · | -96880.0% | -78583.3% | -68075.0% | · | -1157.8% | -1368.4% | -1403.6% | · | -1963.1% | -9930.1% | -4574.2% | · | · | |
| Net Margin | -16315.1% | -272.7% | · | -107660.0% | -198683.3% | 237100.0% | · | 6439.9% | -1082.7% | -1521.2% | · | -2234.0% | -8757.2% | -4020.4% | · | · | |
| Pretax Margin | -19993.9% | -4836.4% | · | -120220.0% | -205400.0% | 232787.5% | · | 6071.1% | -1491.4% | -1851.2% | · | -2749.7% | -10778.3% | -4980.7% | · | · | |
| EBITDA Margin | -21278.8% | -36431.8% | · | -96880.0% | -78583.3% | -67537.5% | · | -1157.8% | -1368.4% | -1345.0% | · | -1963.1% | -9930.1% | -4411.2% | · | · | |
| ROA | -12.8% | -0.12% | · | -15.7% | -28.6% | 42.1% | · | 177.5% | -23.3% | -29.7% | · | -30.9% | -21.4% | -24.0% | · | -45.3% | |
| ROE | -14.8% | -0.14% | · | -38.9% | 65.5% | -159.5% | · | -267.6% | 20.5% | 33.5% | · | 103.0% | 304.9% | -150.2% | · | -119.2% | |
| ROIC | -20.0% | -20.3% | · | · | · | · | · | · | · | · | · | · | · | · | · | · |
流动性与偿付能力
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.2 | 2.0 | · | 0.4 | 0.5 | 0.4 | · | 0.1 | 0.6 | 0.5 | · | 0.6 | 0.8 | 1.1 | · | 1.5 | |
| Quick Ratio | 0.9 | 1.8 | · | 0.3 | 0.4 | 0.3 | · | 0.0 | 0.5 | 0.5 | · | 0.5 | 0.7 | 1.0 | · | 1.4 | |
| Interest Coverage | · | · | · | · | -181.3 | -209.5 | · | · | · | · | · | · | · | · | · | · |
效率
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | · | |
| Inventory Turnover | · | · | · | · | · | · | · | 49.3 | 4.9 | 8.5 | · | · | · | · | · | · | |
| Receivables Turnover | 3.5 | 1.5 | · | 0.5 | 0.1 | 0.2 | · | 38.5 | 7.7 | 21.3 | · | 23.6 | 8.1 | 7.7 | · | · |
每股
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $5.59 | $6.30 | · | $1.41 | $1.86 | $2.68 | · | $-0.46 | $-7.74 | $-7.76 | · | $-0.36 | $-0.29 | $-0.22 | · | $0.10 | |
| Revenue / Share | $0.01 | $0.01 | · | $0.00 | $0.00 | $0.00 | · | $0.02 | $0.11 | $0.12 | · | $0.01 | $0.00 | · | · | · | |
| Cash Flow / Share | · | $-1.66 | · | · | · | $-0.03 | · | · | · | $-1.51 | · | · | · | · | · | · | |
| Cash / Share | $0.60 | $1.03 | · | $0.13 | $0.20 | $0.16 | · | $0.07 | $2.67 | $2.88 | · | $0.22 | $0.34 | $0.49 | · | $0.62 | |
| EPS (TTM) | $-10.52 | $-31.73 | · | $5.00 | $6.73 | $27.62 | · | $-4.27 | $-8.09 | $-9.00 | · | $-21.51 | $-19.42 | $-17.61 | · | · |
估值 (TTM)
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $112.0K | $85.0K | · | $29.0K | $1M | $2M | · | · | · | · | · | · | · | · | · | · | |
| Net Income TTM | $-12M | $-19M | · | $3M | $73M | $74M | · | $24M | $-58M | $-61M | · | $-71M | $-79M | $-90M | · | $-86M | |
| Market Cap | $37M | $64M | · | $10M | $12M | $12M | · | $13M | $8M | $19M | · | $530M | $664M | $564M | · | $1.19B | |
| P/E | -0.6 | -0.3 | · | 2.6 | 2.7 | 0.8 | · | -8.6 | -3.0 | -7.1 | · | -6.2 | -9.5 | -9.6 | · | · | |
| P/S | 332.5 | 748.6 | · | 10278.7 | 355.5 | 182.0 | · | · | · | · | · | · | · | · | · | · | |
| P/B | 1.1 | 1.6 | · | 0.3 | 0.3 | 0.3 | · | -2.7 | -0.1 | -0.3 | · | -12.2 | -21.1 | -25.6 | · | 133.0 | |
| P / Tangible Book | 1.1 | 1.6 | · | 0.3 | 0.3 | 0.3 | · | · | · | · | · | · | · | · | · | 238.0 | |
| P / Cash Flow | · | -24.3 | · | · | · | -7.6 | · | · | · | -1.4 | · | · | · | -34.7 | · | · | |
| Earnings Yield | -177.1% | -312.6% | · | 38.7% | 37.4% | 127.7% | · | -11.6% | -33.1% | -14.0% | · | -16.2% | -10.6% | -10.5% | · | · |
最近期在左侧 · 空值显示为 ·
财务报表 损益表、资产负债表、现金流量表 — 年度，近5年
| 指标 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| 收入 | $71.0K | $3M | $2M | $377.0K | $500.0K |
| 毛利率 % | · | · | · | · | -17.0% |
| 营业利润率 % | -30712.7% | -1482.9% | -2751.8% | -24118.6% | -10878.6% |
| 净收入 | $401.0K | $40M | $-64M | $-89M | $-50M |
| 稀释后每股收益 (EPS) | $-5.63 | $14.90 | $-9.16 | $-15.03 | · |
| 指标 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| 流动比率 | 0.2 | 0.1 | 0.5 | 1.1 | · |
| 速动比率 | 0.1 | 0.0 | 0.4 | 1.0 | · |
| 指标 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| 自由现金流 | $-5M | $-34M | $-52M | $-73M | $-42M |
机构持有人 (13F) 23 家申报者 · $5.6M 总计 · 截至 2026年6月30日
在其季度SEC表格13F中报告持有此股票的机构。仅限多头头寸；单个申报人可能因单独的期权腿而出现两次。 大的抵消性看跌/看涨腿通常反映做市或对冲库存，而非方向性判断。
持有人
23
持有价值
$5.6M
新仓位
4
已退出持仓
5
机构活动 — Q2 2026 与上一季度对比
| 新仓位 | 已退出持仓 | 增加 | 减少 | 净股数变动 |
|---|---|---|---|---|
| 4 (-14 与上一季度对比) | 5 (-7 与上一季度对比) | 6 (+6 与上一季度对比) | 3 (0 与上一季度对比) | +417K |
与Q1 2026对比。 SEC 13F表格的提交截止日期是季度末后45天，外加少量延迟提交的缓冲期——在此窗口期内的季度将被跳过，优先显示最近一个已完整报告的季度对。
激进投资者及 5%+ 股东 4 持仓
提交了 SEC Schedule 13D 的投资者 — 持有超过 5% 的受益所有权，意图影响发行人（激进股东持股、董事会活动、并购）。每一行显示该申报人持仓的最新已知状态。
| 申报人 | 已申报 | 持股 | 状态 | 目的 | 申报 |
|---|---|---|---|---|---|
| Aklog Lishan | 2026年4月9日 | 5.10% | 初始申报 | 被动投资 | SEC |
| Lishan Aklog, M.D., Pavilion Venture Partners LLC | 2018年7月6日 | · | 初始申报 | 被动投资 | SEC |
| Ira Scott Greenspan ×3 申报 | 2018年7月6日 | · | 初始申报 | · | SEC |
| Lishan Aklog, Pavilion Venture Partners LLC, HCFP/Capital Partners III LLC ×3 申报 | 2018年4月26日 | · | 初始申报 | 被动投资 | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
公司内部人士 19 位内幕人士 · 7 位高管 · 10 位董事
| 内部人士 | 角色 | 上次活动 | 持股数量 | 买入 12个月 | 卖出 12个月 | 净额 12个月 |
|---|---|---|---|---|---|---|
| Aklog Lishan | Chairman and CEO | 2026年4月2日 A | 357614 | 0 | 0 | $0 |
| Dennis M Mcgrath | President and CFO | 2026年4月2日 A | 186695 | 0 | 0 | $0 |
| Richard F Fitzgerald | CFO and Secretary | 2016年6月1日 A | 200 | 0 | 0 | $0 |
| Shaun O'Neil | Chief Operating Officer | 2026年4月2日 A | 115598 | 0 | 0 | $0 |
| Victoria Tou-Ho Lee | Chief Medical Officer | 2026年4月2日 A | 71666 | 0 | 0 | $0 |
| Michael Adam Gordon | General Counsel | 2026年4月2日 A | 115000 | 0 | 0 | $0 |
| Brian J. Deguzman | Chief Medical Officer | 2022年2月18日 A | 0 | 0 | 0 | $0 |
| Timothy E Baxter | 董事 | 2026年4月2日 A | 21097 | 0 | 0 | $0 |
| Debra White | 董事 | 2026年4月2日 A | 21097 | 0 | 0 | $0 |
| Sundeep Agrawal | 董事 | 2026年4月2日 A | 19337 | 0 | 0 | $0 |
| Michael J Glennon | 董事 | 2026年4月2日 A | 21653 | 0 | 0 | $0 |
| Ronald M Sparks | 董事 | 2026年4月2日 A | 21097 | 0 | 0 | $0 |
| Joan B Harvey | 董事 | 2024年2月22日 A | 65000 | 0 | 0 | $0 |
| James L Cox | 董事 | 2024年2月22日 A | 65000 | 0 | 0 | $0 |
| David S. Battleman | 董事 | 2021年4月1日 A | · | 0 | 0 | $0 |
| Joshua R Lamstein | 董事 | 2017年12月21日 J | 163177 | 0 | 0 | $0 |
| Matthew Sirovich | 10% 所有者 | 2020年11月25日 S | 1027744 | 0 | 0 | $0 |
| Ira Scott Greenspan | 10% 所有者 | 2018年6月8日 S | 421691 | 0 | 0 | $0 |
| Iv David Weild | · | 2021年4月1日 A | · | 0 | 0 | $0 |
来自SEC表格3/4/5申报的内部人士；净额=仅公开市场买卖
ETF持仓 由 2 只交易所交易基金持有
权重仅反映直接股权持仓（N-PORT）；杠杆基金或基于衍生品的基金可能持有未显示的额外掉期敞口。
PAVM 分析师共识 看涨和看跌分析师观点、12个月价格目标、上涨空间
评级 · 8 位分析师
买入
中位数目标
$36.50
+1171.8%
2 25.0%
强烈买入
5 62.5%
买入
1 12.5%
持有
0 0.0%
卖出
0 0.0%
强烈卖出
12个月价格目标
2 位分析师 · 2026-09-29平均目标 $36.50 +1171.8%
← 低于所有目标
当前价格 $2.87
最低$16.00
平均值$36.50
最高$57.00
同行比较（GICS 子行业） 关键指标与行业同行对比
财年依据，价格截至各公司上一个财年末收盘价。
我的指标 您的个人关注列表 — 来自完整基本面的选定行
选择对您重要的指标 — 点击上方完整基本面中任意行的 + 号。
您的选择已保存，并会跟随您浏览所有股票。
来源：SEC 10-Q 于 八月 13, 2026 申报